Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute kidney injury is associated with worsened outcome for critically ill patients. Sepsis-associated and non-septic cardiothoracic surgery associated AKI have been reported, nonetheless, precise pathomechanistic differences as well as detectability of transcriptional and proteomic changes in correlation with imaging and plasma markers are unclear.
Acute kidney injury is a common and detrimental finding in critically ill/sepsis patients as well as non-septic patients post cardiothoracic surgery. In many cases renal replacement therapy is required and an acute kidney injury is linked to increased morbidity and mortality in intensive care patients. Using routinely obtained clinical samples as well as imaging data, this observational trial investigates the transcriptomic and proteomic determinants detectable in septic and non-septic AKI patient subsets and their correlation with outcome and AKI diagnostic parameters.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Septic AKI patients | Septic AKI patients |
| |
| Non-septic post-cardiothoracic AKI patients | Non-septic post-cardiothoracic surgery AKI patients |
| |
| non-AKI patients undergoing routine nephrectomy | non-AKI patients undergoing routine nephrectomy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No study-specific interventions | Other | Septic AKI patients, post-cardiothoracic AKI patients and non-AKI patients undergoing routine nephrectomy. Due to the observational design of the study, no study-specific interventions are performed. The treatment of the patients is completely guided by the responsible ICU physicians and the respective specialists. |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation of transcriptional and proteomic gene regulation in tissue with clinical molecular Imaging and AKI biomarkers. | Proteomic and RNAseq-based multi-omics pattern recognition. | Through study completion, an average of 1 year. |
| Measure | Description | Time Frame |
|---|---|---|
| Further organ failure based on systemic assessment | Occurrence of organ failure based on hospital data including routinely applied scores, laboratory values or clinical examination. | Through study completion, an average of 1 year. |
| RRT incidence |
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
AKI patients, nephrectomy patients
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alexander Zarbock, MD | Contact | +4925183 | 47252 | zarbock@uni-muenster.de |
| Andreas Margraf, MD | Contact | andreas.margraf@ukmuenster.de |
| Name | Affiliation | Role |
|---|---|---|
| Alexander Zarbock, MD | University Hospital Muenster | Study Chair |
Not provided
Not provided
| ID | Term |
|---|---|
| D058186 | Acute Kidney Injury |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
incidence of renal replacement therapy
| 28 days |
| ICU length of stay | Length of stay for ICU | Through study completion, an average of 1 year. |
| Hospital length of stay | Hospital length of stay | Through study completion, an average of 1 year. |
| Mortality | 28 day mortality | 28 day |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |